All lobbying filings

Thorn Run Partners

Thorn Run Partners filed a Q1 report for Boehringer Ingelheim Pharmaceuticals, Inc. on April 18, 2026, reporting $50,000 in lobbying income.

Lobbying for Boehringer Ingelheim Pharmaceuticals, Inc. · pharmaceutical company

As filed: THORN RUN PARTNERS for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

All filings by Thorn Run Partners · Everything Boehringer Ingelheim Pharmaceuticals, Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 18, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Connecticut

Official filing document

Lobbyists on this filing 1

BEAU SCHUYLER

Previously held: Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Policies related to creating incentives for innovation in the life sciences.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.